John H. Vaughan

6.0k total citations · 1 hit paper
138 papers, 5.0k citations indexed

About

John H. Vaughan is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Rheumatology. According to data from OpenAlex, John H. Vaughan has authored 138 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Immunology, 43 papers in Radiology, Nuclear Medicine and Imaging and 32 papers in Rheumatology. Recurrent topics in John H. Vaughan's work include Monoclonal and Polyclonal Antibodies Research (43 papers), Blood groups and transfusion (19 papers) and T-cell and B-cell Immunology (18 papers). John H. Vaughan is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (43 papers), Blood groups and transfusion (19 papers) and T-cell and B-cell Immunology (18 papers). John H. Vaughan collaborates with scholars based in United States, Canada and United Kingdom. John H. Vaughan's co-authors include Dennis A. Carson, Martin Lotz, John J. Condemi, Ralph F. Jacox, Stephen E. Blomgren, Eugene V. Barnett, Robert I. Fox, Constantine D. Tsoukas, Sherman Fong and John P. Leddy and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

John H. Vaughan

133 papers receiving 4.3k citations

Hit Papers

Effect of Neuropeptides o... 1988 2026 2000 2013 1988 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
John H. Vaughan 1.6k 1.2k 1.1k 966 779 138 5.0k
K Whaley 2.2k 1.3× 796 0.7× 597 0.5× 606 0.6× 868 1.1× 198 4.7k
Senga Whittingham 1.9k 1.2× 941 0.8× 869 0.8× 1.0k 1.1× 420 0.5× 138 6.5k
Burton Zweiman 2.2k 1.4× 968 0.8× 439 0.4× 513 0.5× 1.3k 1.7× 255 5.7k
Glenn E. Nedwin 3.0k 1.9× 492 0.4× 618 0.6× 2.3k 2.4× 369 0.5× 21 6.1k
Igal Gery 4.7k 2.9× 1.4k 1.2× 641 0.6× 1.9k 1.9× 489 0.6× 198 9.0k
Gunnar Husby 1.5k 1.0× 2.5k 2.1× 783 0.7× 3.6k 3.7× 1.3k 1.6× 273 8.2k
Thomas B. Issekutz 3.6k 2.2× 378 0.3× 603 0.6× 1.2k 1.2× 737 0.9× 160 6.8k
Hisao Tomioka 1.8k 1.1× 777 0.7× 530 0.5× 634 0.7× 1.3k 1.6× 140 3.9k
Danielle Burger 1.9k 1.2× 845 0.7× 272 0.2× 1.3k 1.3× 337 0.4× 99 4.5k
Arthur Melms 2.1k 1.3× 536 0.5× 415 0.4× 1.2k 1.2× 370 0.5× 146 8.5k

Countries citing papers authored by John H. Vaughan

Since Specialization
Citations

This map shows the geographic impact of John H. Vaughan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John H. Vaughan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John H. Vaughan more than expected).

Fields of papers citing papers by John H. Vaughan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John H. Vaughan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John H. Vaughan. The network helps show where John H. Vaughan may publish in the future.

Co-authorship network of co-authors of John H. Vaughan

This figure shows the co-authorship network connecting the top 25 collaborators of John H. Vaughan. A scholar is included among the top collaborators of John H. Vaughan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John H. Vaughan. John H. Vaughan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Aichinger, Gerald, Lars Karlsson, Michael R. Jackson, et al.. (1997). Major Histocompatibility Complex Class II-dependent Unfolding, Transport, and Degradation of Endogenous Proteins. Journal of Biological Chemistry. 272(46). 29127–29136. 35 indexed citations
3.
Vaughan, John H.. (1995). The Epstein-Barr virus in autoimmunity. Springer Seminars in Immunopathology. 17(2-3). 203–230. 27 indexed citations
4.
Handley, Harold H., et al.. (1995). Purification of Recombinant Human Hsp60: Use of a GroEL-free Preparation to Assess Autoimmunity in Rheumatoid Arthritis. Journal of Autoimmunity. 8(5). 659–673. 6 indexed citations
5.
Vaughan, John H.. (1993). Pathogenetic concepts and origins of rheumatoid factor in rheumatoid arthritis. Arthritis & Rheumatism. 36(1). 1–6. 62 indexed citations
6.
Petersen, Jørgen Holm, Gary Rhodes, Jean Roudier, & John H. Vaughan. (1990). Altered immune response to glycine‐rich sequences of epstein‐barr nuclear antigen‐1 in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis & Rheumatism. 33(7). 993–1000. 38 indexed citations
7.
Bentin, Jacques, Constantine D. Tsoukas, J. Allen McCutchan, et al.. (1989). Impairment in T-lymphocyte responses during early infection with the human immunodeficiency virus. Journal of Clinical Immunology. 9(2). 159–168. 28 indexed citations
8.
Petersen, Jørgen Holm, et al.. (1989). Human T cell responses to the Epstein-Barr nuclear antigen-1 (EBNA-1) as evaluated by synthetic peptides. Cellular Immunology. 123(2). 325–333. 8 indexed citations
9.
Vaughan, John H., Timo Kouri, Jørgen Holm Petersen, Jean Roudier, & Gary Rhodes. (1988). On the Etiology of Rheumatoid Arthritis. Scandinavian Journal of Rheumatology. 17(sup74). 19–28. 16 indexed citations
10.
Bentin, Jacques, John H. Vaughan, & Constantine D. Tsoukas. (1988). T cell proliferation induced by anti‐cd3 antibodies: requirement for a t‐t cell interaction. European Journal of Immunology. 18(4). 627–632. 15 indexed citations
11.
Tsoukas, Constantine D., Mary A. Valentine, Martin Lotz, John H. Vaughan, & Dennis A. Carson. (1984). The role of the T3 molecular complex in antigen recognition and subsequent activation events. Immunology Today. 5(11). 311–313. 38 indexed citations
12.
Tsoukas, Constantine D., Dennis A. Carson, Sherman Fong, et al.. (1982). Lysis of autologous Epstein-Barr virus-infected B cells by cytotoxic T lymphocytes of rheumatoid arthritis patients. Clinical Immunology and Immunopathology. 24(1). 8–14. 11 indexed citations
13.
Johnson, J. S., et al.. (1976). Altered lymphocyte reactivity in rheumatoid arthritis. Arthritis & Rheumatism. 19(3). 509–515. 83 indexed citations
14.
Vaughan, John H.. (1973). Coming in postgraduate medicine. Postgraduate Medicine. 54(4). 20–20.
15.
Barnett, Eugene V. & John H. Vaughan. (1966). ANTINUCLEAR ANTIBODIES IN RABBIT ANTISERA. The Journal of Experimental Medicine. 123(4). 733–746. 21 indexed citations
16.
Allen, Peter Z., Stitaya Sirisinha, & John H. Vaughan. (1965). Immunochemical Studies on Equine Antibodies to Human γ2-Globulin. The Journal of Immunology. 95(5). 918–928. 5 indexed citations
17.
George, Mariam & John H. Vaughan. (1962). Observations on the Nature of the Antigen in Tanned Red Cell Hemagglutination,. The Journal of Immunology. 88(2). 191–198. 9 indexed citations
18.
Dutton, Richard, Anne H. Dutton, Mariam George, Robert Q. Marston, & John H. Vaughan. (1960). Phosphate Metabolism of Spleen Cells in Antibody Formation. The Journal of Immunology. 84(3). 268–272. 8 indexed citations
19.
Vaughan, John H.. (1956). Behavior of the Rheumatoid Arthritis Agglutinating Factor with Immune Precipitates,  . The Journal of Immunology. 77(3). 181–188. 54 indexed citations
20.
Vaughan, John H. & Elvin A. Kabat. (1953). STUDIES ON THE ANTIBODIES IN RABBIT ANTISERA RESPONSIBLE FOR SENSITIZATION OF HUMAN SKIN. The Journal of Experimental Medicine. 97(6). 821–844. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026